STOCK GOODIES PLAYS OF THE WEEK

[budfoxfun]

$RXMD The Walmart offer for PillPack comes at a critical time for RXMD. Until recently there have been few comparable pharmacies offering services similar to PharmCo, LLC. The market cap for RXMD has ranged between $4 million and $100 million. Now that PillPack is being offered a dollar figure from Walmart, RXMD has a way to assess what their Company is worth. Walmart’s current offer is slightly less than a $1 billion, however, it is widely assumed the transaction will close around that figure. At close to $100 million in revenue nationwide, PillPack’s valuation could provide needed clarity on the value of RXMD. RXMD released audited financial statements for 2017 indicating over $20 million in sales, the bulk of which is in the South Florida area. Like PillPack, RXMD’s model is absolutely invested in the safety and well-being of their patients.

One of the main focusses for RXMD is on Medication Management Therapy, and their success is measured by their positive cash flow and $20 million in net revenues. Managed care isn’t just good for patients, but for their doctors as well. Patients look to their doctors to both prevent and heal diseases, and they’ll measure their physician based on their success. By stressing a more proactive approach to the patient, the preventative care can naturally follow. RXMD currently offers a wide range of services that center around adherence and compliance to improve patient health outcomes. Free same day and next day delivery throughout South Florida, access to a full inventory of medications including specialty and compounded drugs, risk management services to physicians, and home health assessments for patients struggling with their medication regiment are just some of the services that take RXMD’s approach to the next level. https://smallcapvoice.com/blog/rumored-walmart-deal-adds-value-and-more-to-the-progressive-care-approach/